| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |